Increased isoprene production using the archaeal lower mevalonate pathway
First Claim
Patent Images
1. A method of increasing the rate or flux of production of 3,3-dimethylallyl diphosphate (DMAPP), isopentenyl diphosphate (IPP), or a product derived from DMAPP and/or IPP comprising:
- culturing recombinant cells comprising (i) one or more heterologous non-modified nucleic acids encoding feedback-resistant mevalonate kinase polypeptides, and (ii) one or more nucleic acids encoding a mevalonate (MVA) pathway polypeptide, wherein the cells are cultured under suitable culture conditions for increasing the rate or flux of production of DMAPP, IPP, or a product derived from DMAPP or IPP,thereby increasing the rate or flux of production of DMAPP, IPP, or a product derived from DMAPP and/or IPP.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention features methods for producing isoprene from cultured cells using a feedback-resistant mevalonate kinase polypeptide, such as an archaeal mevalonate kinase polypeptide. The resulting isoprene compositions may have increased yields and/or purity of isoprene.
28 Citations
21 Claims
-
1. A method of increasing the rate or flux of production of 3,3-dimethylallyl diphosphate (DMAPP), isopentenyl diphosphate (IPP), or a product derived from DMAPP and/or IPP comprising:
-
culturing recombinant cells comprising (i) one or more heterologous non-modified nucleic acids encoding feedback-resistant mevalonate kinase polypeptides, and (ii) one or more nucleic acids encoding a mevalonate (MVA) pathway polypeptide, wherein the cells are cultured under suitable culture conditions for increasing the rate or flux of production of DMAPP, IPP, or a product derived from DMAPP or IPP, thereby increasing the rate or flux of production of DMAPP, IPP, or a product derived from DMAPP and/or IPP. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
Specification